Virginia Drug Discovery Consortium
The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:
To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.
To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.
To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.
VirginiaDrugDiscoveryRx: A Symposium on Academic-Industrial Partnerships in Drug Discovery
June 25-26, at the Founders Hall, George Mason University: A symposium themed “Building Drug Discovery Partnerships” featuring presentations by successful entrepreneurs who have translated basic research into biotech companies, and by other drug discovery researchers who have promising drug candidates in development. The meeting is hosted by the Virginia Drug Discovery Consortium and VirginiaBio.
Who should attend?
- Virginia scientists with drug discovery related research
- Investors looking for promising new drug start-up companies
- Pharmaceutical and Biotech companies looking for new leads
Frank Gupton receives a $25M award from the Gates foundation for the "Medicines for All" Initiative" The Bill & Melinda Gates Foundation has awarded the Virginia Commonwealth University School of Engineering $25 million to create the Medicines for All Institute, a...read more
John Lazo (VaDDC, Univ. of Virginia Pharmacology), David Kingston (VaDDC, Virginia Tech Chemistry) and Thomas Loughran (Director, Univ. of Virginia Cancer Center) were interviewed by Charlottesville’s CBS affiliate regarding Virginia Drug Discovery Consortium’s 2017...read more
Professor Rob Gourdie, Director of the Virginia Tech Carilion Research Institute’s (VTCRI) Center for Heart and Regenerative Medicine Research, previously founded First String Research Inc., which is poised to commercialize a treatment for debilitating foot ulcers in...read more
Want to work with us?
If you are interested in supporting this initiative, please contact us.